# GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results
Canonical URL: https://biopharmsignal.com/news/GOCO/gohealth-to-announce-strategic-capital-and-governance-actions-to-support-long-te-6cf66f2c
Ticker: GOCO
Company: GoHealth
Source: GoHealth
Published: 2025-08-06 20:15 EST
## Summary

GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital...

## Article Body
GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025.

Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss recent strategic capital and governance actions.

A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/ . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.

About GoHealth, Inc.

GoHealth is a leading health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers’ peace of mind when making healthcare decisions so they can focus on living life. For many of these consumers, enrolling in a health insurance plan is confusing and difficult, and seemingly small differences between health plans may lead to significant out-of-pocket costs or lack of access to critical providers and medicines. GoHealth’s proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs. Its unbiased, technology-driven marketplace coupled with highly skilled licensed agents has facilitated the enrollment of millions of consumers in Medicare plans since GoHealth’s inception. For more information, visit https://www.gohealth.com .

Investor Relations John Shave jshave@gohealth.com Media Relations Pressinquiries@gohealth.com
## Recent Company News
- 2026-07-21 20:12 EST — [GoHealth Successfully Completes Financial Restructuring and Emerges Well Positioned for Future Success](https://biopharmsignal.com/news/GOCO/gohealth-successfully-completes-financial-restructuring-and-emerges-well-positio-242faf08) — Source: GoHealth
- 2026-06-07 19:40 EST — [GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders](https://biopharmsignal.com/news/GOCO/gohealth-inc-to-strengthen-its-position-ahead-of-aep-2026-through-restructuring--56003736) — Source: GoHealth
- 2026-03-31 20:20 EST — [GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results](https://biopharmsignal.com/news/GOCO/gohealth-prioritizes-consumer-fit-renewal-economics-and-cash-discipline-while-co-2b57e179) — Source: GoHealth
- 2025-11-13 12:00 EST — [GoHealth Prioritizes Retention, Quality, and Strategic Flexibility as Medicare Advantage Market Rationalizes; Reports Third Quarter 2025 Results](https://biopharmsignal.com/news/GOCO/gohealth-prioritizes-retention-quality-and-strategic-flexibility-as-medicare-adv-16f7a495) — Source: GoHealth
- 2025-11-11 14:00 EST — [GoHealth to Announce Third Quarter 2025 Results on November 13, 2025](https://biopharmsignal.com/news/GOCO/gohealth-to-announce-third-quarter-2025-results-on-november-13-2025-67798cda) — Source: GoHealth
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)